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ORIGINAL ARTICLE Reproductive biology
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background: In mouse endometrium, glycogen synthase kinase-3ß (GSK3ß) is a key enzyme controlling nuclear localization of cyclin
D1. We developed a functional model of xenografted human endometrium to test whether similar mechanisms are operative in the human
by using Lithium chloride (LiCl), an inhibitor of GSK3ß.
methods: Human endometrial samples were obtained from normal volunteers, then implanted under the kidney capsule of nude mice,
and treated with estradiol-17ß (E2) or LiCl. Xenografts were assessed for protein expression of MKI-67, mini-chromosome maintenance
protein-2, estrogen receptor (ER), progesterone receptor (PR) and cyclin D1.
results: Both E2 and LiCl induced a robust proliferative response in the epithelium. Only lithium treatment produced clear nuclear local-
ization of cyclin D1 consistent with the proliferative response observed. Regenerated endometrium had detectable ER and PR expression.
conclusion: Xenografted human endometrium provides a dynamic model of uterine biology. Administration of LiCl in the absence of
E2 induced epithelial proliferation, supporting the hypothesis that human and murine endometrial proliferation may share key regulatory path-
ways. These data suggest a possible link between the increased menstrual disturbances in women with affective disorders taking lithium and
the consequent potential for the development of endometrial proliferative disorder.
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Introduction
In women, hormonal states that result in unopposed estrogen stimu-
lation are associated with menstrual irregularities and an increased risk
of endometrial hyperplasia and adenocarcinoma (Deligdisch, 2000).
Uterine corpus cancer is the most common gynecologic malignancy
in Western countries (Bray et al., 2005; Jemal et al., 2008). Although
progestins have been extensively used in treating endometrial hyper-
plasia and selected cases of endometrial carcinoma (Kim et al.,
1997), molecular mechanisms of sex steroids interaction in the
human endometrium remain incompletely understood. Estradiol-17ß
(E2) and progesterone (P4) coordinately regulate cyclic endometrial
regeneration. E2 induces cell proliferation of the uterine epithelium,
although P4 inhibits this cell proliferation and triggers differentiation.
In the mouse, endometrial epithelial cell proliferation is regulated by
E2 activation of the canonical cell-cycle machinery. This is
accomplished by the inactivation of a tumor-suppressor protein pRB
and related family members via phosphorylation by cyclin/cyclin
dependent kinases (Hatakeyama et al., 1994). In particular, E2 treat-
ment causes the nuclear accumulation of cyclin D1 that, together
with its partners CDK4 and CDK6, phosphorylates pRb at speciﬁc
sites with the resultant progression of cells towards S-phase (Tong
et al., 2008). The cellular localization of cyclin D1 is governed by gly-
cogen synthase kinase-3ß (GSK3ß) (Takahashi-Yanaga and Sasaguri,
2008). This key mediator of intracellular signaling is also involved in
the canonical Wnt signaling pathway where it interacts with
ß-Catenin and was recently found to play a role in regulation of
uterine epithelial cell proliferation (Hou et al., 2004; Wang et al.,
2007). GSK3ß phosphorylates cyclin D1 on Thr286 increasing its
efﬂux from the nucleus. GSK3ß enzyme activity is inhibited by E2 treat-
ment through an inhibitory phosphorylation by AKT1 at Ser9 (Diehl
et al., 1998; Alt et al., 2000). AKT1, in turn, is activated by
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phosphorylation in response to PI3-kinase activation by an IGF-1
receptor mediated mechanism that is up-regulated by E2. Studies indi-
cate that whereas the binding of E2 to its receptor (ERa) is required
for the stimulation of cell proliferation, once the pathway is started it
becomes ER-independent (Hall et al., 2001; Levin, 2005). Consistent
with this observation, inhibition of GSK3ß in the absence of E2
induces DNA synthesis in the mouse uterine epithelium (Zhu and
Pollard, 2007). This pathway is inhibited by P4 that acts to block
E2-induced AKT1 activation with the consequent maintenance of acti-
vated GSK3ß and nuclear exclusion of cyclin D1.
Mechanistic studies of the sex steroid hormone regulation of human
endometrial epithelial cell proliferation are hindered by the inability to
safely administer potentially toxic agents to volunteers. To overcome
these problems, researchers have used human endometrial tissue
xenografts to examine hormonal regulation of gene expression
(Satyaswaroop and Tabibzadeh, 2000), endometriosis (Fasciani
et al., 2003) and uterine stroma-epithelial interactions (Kurita et al.,
2005). In this study, we modiﬁed a previously published protocol
that entailed collecting endometrial biopsies from healthy volunteers,
recombining endometrial glands and stroma in collagen gels, and trans-
planting the xenografts under the kidney capsule of nude mice (Cunha
and Young, 1992; Cooke et al., 1997) to study the regulation of cell
proliferation. We sought to test the hypothesis that, as in the
mouse, inhibition of GSK3ß in the absence of E2 is sufﬁcient to
cause a proliferative response in human endometrium.
Materials and Methods
Human endometrial tissue acquisition
Human endometrial tissue was acquired by biopsy from healthy female
volunteers, ages 18–45, recruited from the community. Inclusion criteria
for the study required regular menstrual cycles and no history of gyneco-
logical disease. Women who were breast-feeding or using hormonal con-
traception within 3 months of study entry were excluded. Screening done
speciﬁcally for study purposes included negative urine pregnancy test,
normal pap smear and a normal saline hysterosonogram. Endometrial
biopsies were timed to be performed in the proliferative phase, days 9–
12 after the ﬁrst day of menses. All biopsies were performed by aspiration
using a Pipelle catheter (Unimar, Wilton, CT, USA) with the aim of
sampling fundal endometrium. The protocol was approved by the Insti-
tutional Review Board, Monteﬁore Medical Center and by the General
Clinical Research Center Advisory Committee, Albert Einstein College
of Medicine in accordance with the Declaration of Helsinki for Medical
Research. Informed consent was obtained from all participants.
Preparation of endometrial cell extracts
The aspirated endometrial tissue was immediately washed in prewarmed
McCoy’s 5A medium (Invitrogen, Carlsbad, CA, USA) to remove blood
and mucus. Subsequently, the tissue was minced for 5 min into 2–3 mm
pieces and digested with collagenase type I (1.5 mg/ml; Worthington,
Freehold, NJ, USA) and DNAase I (1.0 U/ml; Sigma Aldrich, St Louis,
MO, USA) in McCoy’s 5A medium. The cell suspension was placed in a
shaking water bath at 378C for 20 min. This procedure was performed
three times with intermittent pipetting. The digested tissue suspension
was subjected to centrifugation at 100  g for 5 min. Next, using an estab-
lished protocol of separating stroma from epithelium (Osteen et al., 1989),
the suspension was ﬁltered through a sterilized 85 mm nylon mesh ﬁlter
(Small Parts, Miramar, FL, USA).
Retained tissue from the ﬁrst ﬁltration was digested with hyaluronidase
(0.5%; Sigma), protease (0.5%; Sigma) and DNase I in McCoy’s medium
for 20 min. In this fashion, the epithelial cells are segregated as organoids
(Fig. 1A) containing several glands in an effort to preserve physiological
tissue orientation (Kurita et al., 2005). This method had been shown to
yield pure isolates of stromal and epithelial compartments of human endo-
metrium (Parekh et al., 2002).
The ﬁltrate from the ﬁrst ﬁltration containing the stromal cells was then
separated from the remaining red blood cells with one-layer Percoll
(Sigma) density gradient. In order to obtain a single cell preparation of
stromal cells, the suspension was then passed through a sterilized
20 mm nylon mesh ﬁlter (Small Parts). In general, one endometrial
biopsy yielded 10–20 million of each epithelial and stromal cells sufﬁ-
cient for grafting 10–20 hosts.
Animals and treatments
Adult female nude mice were obtained from Taconic Farms
(Germantown, NY, USA) and were maintained in accordance with the
NIH Guide for Care and Use of Laboratory Animals. The Animal Institute
Committee of Albert Einstein College of Medicine approved all pro-
cedures and protocols. Tissue recombinants were engrafted under the
kidney capsule using a modiﬁed protocol described by Cunha (Cunha
and Young, 1992; Cooke et al., 1997; http://mammary.nih.gov/tools/
mousework/Cunha001/index.html). Brieﬂy, freshly isolated uterine
stroma and epithelium were recombined onto 30 ml of rat-tail collagen
gel (BD Biosciences, Bedford, MA, USA) by placing three to ﬁve epithelial
organoids and approximately 500 000 stromal cells per tissue recombi-
nant. The recombinants were allowed to gel under room temperature.
Kidney grafting was conducted via a dorsal incision under tribromoethanol
(2.5%) anesthesia. One xenograft was implanted under the kidney capsule
of each adult intact 8–10-week-old female nude mice. After allowing
6 weeks for tissue outgrowth, the hosts were ovariectomized via a
dorsal incision. In most experiments, mice were then divided into
groups of two to ﬁve animals per group according to the following treat-
ments: (a) 5 days of daily subcutaneous injections of 125 ng of E2 (0.1 ml
in peanut oil), starting 2 weeks after ovariectomy, (b) 20 days of drinking
tap water with 0.05% lithium chloride (LiCL) (Sigma), (c) oil injections only
and drinking plain tap water (controls). A concentration of lithium of
0.05% in drinking water has been demonstrated to result in proliferation
of eutopic uterine epithelium in mice (Gunin et al., 2004). Animals were
euthanized 18 h after the last E2 injection based on known kinetics of
maximal proliferative response in xenografted endometrium (Kurita
et al., 2005). Each experiment was repeated at least twice.
Histology and immunohistochemistry
At the end of the experimental protocol, the animals were killed in a carbon
dioxide chamber in accordance with the guidelines on euthanasia of
laboratory animals (AVMA, 2001). Xenografts were harvested, ﬁxed with
peroxidate– lysine–2% paraformaldehyde–0.05% glutaraldehyde, and pro-
cessed for parafﬁn embedding. Cross sections (5-mm thickness) were
mounted on glass slides and stained with hematoxylin and eosin. Two
methods were used to conﬁrm the species of origin of the tissue harvested
from xenotransplantation. Staining with Hoechst dye produces character-
istic punctuated nuclear staining in mouse tissues and homogenous staining
of human nuclei (Cunha and Vanderslice, 1984). After treating the tissue
with 1 mg/ml Hoechst 33258 dye (Sigma) for 1 min, the slides were
washed and mounted with Vectashield (Vector Laboratories, Burlingame,
CA, USA) and examined by ﬂuorescent microscopy. To further conﬁrm
the human origin of cells, in situ hybridization (ISH) for a human speciﬁc
probe (Alu) was performed: after deparafﬁnization, sections were incubated
with digoxigenin-labeled Alu probe (Invitrogen) at 378C overnight.
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Hybridization was detected by using the anti-digoxigenin-AP antibody and
developed by NTP/PCIP (Roche Applied Science, Indianapolis, IN, USA)
as previously described (Pan et al., 2006).
Two markers were used as surrogates for cell proliferation: the antigen
identiﬁed by monoclonal antibody Ki-67 (MKI67) and mini-chromosome
maintenance deﬁcient 2, mitotin (S. cerevisiae) (MCM2). Sex-steroid
receptor (estrogen receptor, ERa, and progesterone receptor, PR)
expression was assessed as a surrogate for hormonal receptivity of the
xenografted endometrium. Monoclonal antibodies were used at the fol-
lowing concentrations: MKI67 (1:200, MB67, Neomarkers, Fremont,
CA, USA), and cyclin D1 (1:100, Lab Vision, Fremont, CA, USA) and
ERa (1:300, sc-8005, Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Polyclonal antibodies were purchased from Santa Cruz Biotechnology
and were used to detect expression of MCM2 (goat IgG, 1:300;
sc-9839) and PR (rabbit IgG, 1:300; sc-538).
Immunohistochemical procedures were performed as previously
described (Tong and Pollard, 1999). Brieﬂy, 5 mm parafﬁn sections were
deparafﬁnized and subjected to antigen retrieval by boiling the samples
in 0.01 M sodium citrated buffer. The primary antibody was applied
either for 60 min at room temperature (MKI67) or overnight at þ48C.
The incubation times were kept consistent per antibody to optimize the
staining, after which sections were washed in phosphate-buffered saline
and then incubated with biotin-conjugated secondary antibodies (Vector
Laboratories). Positive signals were visualized as brown precipitates utiliz-
ing 3,30-diaminobenzidine tetrahydrochloride (Sigma). Sections were coun-
terstained with hematoxylin. Negative controls included replacement of
the primary antibody with either non-speciﬁc rabbit, goat or mouse immu-
noglobulin or saline. Immunopositive glandular epithelial cells were
counted through the microscope at a magniﬁcation of 100 with a mech-
anical tabulator. As described by others (Brenner et al., 2003), the protein
Figure 1 Human endometrial tissue engrafted under the mouse renal capsule organizes into histologically normal uterine tissue.
(A) Phase contrast microscopy of the human endometrial epithelial cells isolated as organoids to preserve the physiological polarity of the tissue. (B) Macroscopic ﬁndings
of the transplanted site of nude mice kidney harvested 6 weeks after transplantation. (C and D) H&E staining demonstrates several histologically normal uterine gland and
stroma of human origin adjacent to mouse kidney parenchyma. (E) The species origin of the xenograft conﬁrmed by staining with Hoechst 33258 dye shows characteristic
punctuated nuclei in mouse cells and homogenous pattern in human cells. (F) ISH for human Alu-speciﬁc probe shows intense staining of the xenograft glands and stroma
and no staining of the mouse parenchyma. Original magniﬁcation: (A) 20, (C) 5, (D) 40, (E) 20, (F) 10.
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expression was calculated as the labeling index, the proportion (%) of posi-
tively stained nuclei over the total number of nucleated cells present. Stat-
istical comparisons were performed by Student’s t test.
Results
Engraftment of human endometria under the kidney capsule had an
approximately 50% success rate in our hands and is easily identiﬁed
by the relatively avascular region on the surface (Fig. 1B). After
6 weeks of outgrowth, transverse histological sections revealed a mor-
phological, vascularized endometrium with characteristic epithelial
structures penetrating into a stroma that is clearly demarked from
the underlying mouse kidney (Fig. 1C, D). Staining with Hoechst
33258 that gives characteristic nuclear morphology for mouse and
human nuclei was used to determine the extent of contribution
from mouse cells and to conﬁrm the human origin of the graft and
it limits (Cunha and Vanderslice, 1984). This showed that the xeno-
transplanted tissues were largely made up of human cells with only
very limited hematopoietic inﬁltrate from the mouse (Fig. 1E). This
relative lack of mouse contribution was conﬁrmed by ISH for the
human-speciﬁc Alu probe that revealed intense hybridization to the
nuclei of the xenograft glands and stroma with none in the mouse
tissue (Fig. 1F).
The endometrium is a classical sex steroid hormone target tissue
characterized by ER and PR expression. Immunohistochemistry
(IHC) for ERa using anti ERa antibodies revealed strong expression
of ERa in the human xenotransplants following ovariectomy of the
host mice. This was especially strong in the epithelial compartment
with lesser expression in the stroma (Fig. 2). E2 treatment of the ovari-
ectomized mice produced a relative down-regulation of ERa immuno-
histochemical staining (Fig. 2B) as compared with control (Fig. 2A).
This treatment with E2 also resulted in an up-regulation of PR in
both the stroma and epithelium of the xenografts (Fig. 2E) as
compared with control (Fig. 2D). This hormone receptor expression
suggests that the tissue will be responsive to these hormones. This
can be seen by the induction of a characteristic stromal edema follow-
ing E2 treatment of the ovariectomized mice (Fig. 2B, E).
Ovariectomized mice had a low level of cell proliferation in both the
stromal and epithelial compartment as assessed by the surrogate pro-
liferation markers, MKI67 and MCM2. E2 treatment induced a charac-
teristic proliferative response in the epithelium that was signiﬁcantly
elevated by about 3.5-fold over the ovariectomized controls as
assessed by MKI67 or MCM2 staining (Figs. 3A, D and 4). Notably,
MCM2 IHC revealed a greater proportion of proliferating cells
(80%) than did MKI67 (30%) staining, although the proportional
increment over controls was similar for these two markers (Figs. 3B,
E and 4). Interestingly, this MKI67 and MCM2 nuclear expression
was restricted to the epithelial compartment, with little in the
stroma (Fig. 3).
To test the hypothesis that E2 signaling was through GSK-3b inhi-
bition, we treated the ovariectomized xenotransplanted mice by
oral administration of 0.05% LiCl, a relatively speciﬁc inhibitor of
GSK3ß at this concentration (Rossig et al., 2002; Gunin et al., 2004)
in the absence of E2. Xenotransplanted mice treated with LiCl for
20 days resulted in a statistically signiﬁcant increase in the proportion
of proliferating cells compared with control, as assessed by MKI67 and
MCM2 staining (Figs. 3G, H and 4). The numbers of proliferating cells
was similar to that observed with chronic E2 treatment.
In the mouse, inhibition of GSK3ß results in the nuclear localization
of cyclin D1 in the uterine epithelial cells (Zhu and Pollard, 2007). To
determine if this is the case for the endometrial transplants we immu-
nostained the human endometrial tissue with an anti-cyclin D1 anti-
body. The endometrial transplants from ovariectomized mice
showed little cyclin D1 staining in any cell type (Fig. 3C). Treatment
with E2 resulted in an up-regulation, although this was mostly but
not exclusively cytoplasmic (Fig. 3F). In contrast, LiCl treatment
Figure 2 Human xenografts exhibit robust ER and PR expression.
Xenograft in an ovariectomized mouse without any hormonal treatment shows robust expression of ER by IHC (A). ER expression is down-regulated after E2 treatment
(B). Negative IHC control with normal mouse (C) and rabbit (F) IgG. PR IHC of a xenotransplant in a mouse treated with E2 (D) demonstrates edema associated with E2
treatment and up-regulation of PR as compared with ovariectomized control (E). Brown staining indicates positive cells; two replicate experiments were conducted with
same results. Original magniﬁcation 100.
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Figure 3 Human xenografts respond to E2 and LiCl treatment with DNA synthesis.
IHC staining of cell-cycle markers in human endometrial xenografts harvested from the host that were treated with 5 days of daily subcutaneous injections of 125 ng of
17B-estradiol (E2), 20 days of drinking tap water with 0.05% LiCl, or injected with oil only and were drinking plain tap water (control). As compared with controls (A–C),
protein expression of MKI67, MCM2, and cyclin D1 was greater in E2 (D–F) and LiCl (G– I) treated xenografts. Brown staining indicates positive cells; three replicate
experiments were conducted with same results. Original magniﬁcation: (C), (F), (I) 100; otherwise 40.
Figure 4 Epithelial labeling index for MKI67 and MCM2.
Results of three replicate experiments are summarized and are expressed as mean+ standard deviation. * Signiﬁes P, 0.01, compared with control.
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produced robust nuclear cyclin D1 staining in the xenografted epi-
thelium (Fig. 3I) compared with the ovariectomized control group.
Discussion
Signiﬁcant advances have been made in recent years in the understand-
ing of uterine physiology, especially as it pertains to themolecular switch
from E2 to P4-dominated signaling (Tong et al., 2008). Although it has
been enormously helpful to use the mouse as an informative model
system amenable to biochemical (Tong and Pollard, 1999) and genetic
(Niklaus and Pollard, 2006) analysis, it is necessary to have a similar
understanding in humans. Ex-vivo studies of human endometrial biopsies
from normal reproductive aged women have given us insight at both the
transcript and protein level (Niklaus et al., 2007), but have signiﬁcant
limitations for mechanistic studies. For this reason, we have used and
improved a model in which immuno-compromised mice are trans-
planted with disaggregated and recombined human epithelial glands
and stroma (Cunha and Young, 1992).
In this work, we demonstrate that human endometrial tissue xeno-
grafts retain their hormonal receptivity and capacity to proliferate in
response to estrogen treatment. We demonstrate that they express
ER and PR in the appropriate tissue compartments. Furthermore, the
response of the expression of ER and PR to E2 is similar to that found
in normal human endometrium (Brenner and Slayden, 2005; Niklaus
et al., 2007). Additionally, there is a profound stromal edema response
to E2 that is also comparable to that observed in the menstrual cycle.
The degree of the proliferative reaction we observed in our xenografts
is similar to that found in the work of others who have extensively
manipulated human xenografts to study epithelial-stromal interactions
(Kurita et al., 2005). In addition to the classic use of MKI67 as an indi-
cator of uterine proliferative activity, we observed an even stronger
MCM2 response to exogenous E2. MCM proteins are part of the
DNA replication licensing complex that marks the origin of DNA repli-
cation and are essential for S-phase entry. Others have noted a higher
proportion of MCM2 as compared with MKI67 stained proliferating
cells in studies that performed side-by-side comparison of these anti-
bodies as markers of cellular proliferation. In several studies of prema-
lignant and malignant lung cells, anti-MCM2 antibodies stain a higher
proportion of cells than do anti-Ki-67 antibodies (Ramnath et al.,
2001; Tan et al., 2001). This divergence of data is difﬁcult to explain
on a mechanistic level due to the fact that a biological function of the
protein that possesses the Ki-67 epitope is unknown (Endl and
Gerdes, 2000). Further, MCM2 has been demonstrated as a reliable
marker for endometrial hyperplasia (Kato et al., 2003) and, most
recently, breast carcinoma (Reena et al., 2008). This data suggests
that MCM2 expression in the endometrium will be a useful indicator
of competence for a cell to enter into DNA synthesis. To conﬁrm
this, sustained incorporation of BrDU will need to be performed, as
this is a deﬁnitive marker of DNA synthesis. Nevertheless, the data
taken together have demonstrated that these xenotransplants of endo-
metrial tissue provide a pathophysiologically relevant model in which to
study human endometrial biology.
Work from our group points to GSK3ß as a central point in regulat-
ing the molecular switch from E2 to P4 dominated signaling in uterine
epithelium. The cascade of events that trigger cell proliferation is
initiated by E2 and ultimately leads to cyclin D1 nuclear accumulation
that, in turn, results in cell cycle progression (Tong and Pollard, 1999).
The cellular localization of cyclin D1 is governed by GSK3ß which is
constitutively active at rest, favoring transportation of cyclin D1 out
of the nucleus through a phosphorylation of Thr286 that allows inter-
action with the nuclear exportin, CREM1 (Alt et al., 2000). Upon E2
stimulation, activation of PI3K results in activating phosphorylation of
protein kinase B (AKT) that, in turn, causes an inhibitory phosphoryl-
ation of GSK3ß. This inactivated GSK3ß no longer phosphorylates
cyclin D1 and thus it accumulates in the nucleus where it together
with its CDK partners 4 and 6 phosphorylates pRB and progression
of the cell cycle (Tong and Pollard, 1999). Although P4 treatment sup-
presses this pathway, inhibition of GSK3ß reverses the P4 effect and
results in progress towards DNA synthesis (Chen et al., 2005).
LiCl is an allosteric inhibitor of GSK3ß that inhibits its activity in a
manner that is distinctly different to the mode of action of E2 (Rossig
et al., 2002). In mice, LiCl had been demonstrated to augment the mag-
nitude of the E2 proliferative effect (Gunin et al., 2004) as well as to
result in endometrial proliferation in the absence of E2 (Zhu and
Pollard, 2007). Although LiCl affects a multitude of signaling pathways,
its mode of action on GSK3ß has been well correlated with the
similar response to action of speciﬁc inhibitors of this enzyme
(Fuentealba et al., 2007). Indeed, inhibition of GSK3ß using a more
speciﬁc inhibitor SB415286 applied directly to the uterine luminal
epithelium in mice also results in an E2-independent induction of
DNA synthesis (Zhu and Pollard, 2007), indicating that it acts down-
stream of the ER. In the present study, we show that the human endo-
metrium also responds to LiCl by DNA synthesis in an E2 independent
manner.
One of the hypotheses that we tested was whether cyclin D1
expression in the nucleus of human uterine epithelial cells occurs
co-incident with the proliferative response in a manner similar to the
mouse. Although lithium treatment produced robust nuclear staining
in the xenografted epithelium, E2-treated glands exhibited staining
that was largely restricted to the cytoplasm. Thus, we were not able
to conﬁrm the pattern of nuclear localization of cyclin D1 that is charac-
teristic for the mouse response of uterine epithelium to E2. However,
differences in the respective treatments may account for the observed
results. Lithium administration in drinking water that is consumed ad lib
throughout the day is expected to produce a sustained serum concen-
tration. In contrast, once-a-day injection of E2 is known to result in a
transient peak of ER occupancy 2 h after administration (Martin et al.,
1976). Consequently in the mouse uterine epithelium, there is a tem-
porally brief window of nuclear expression of cyclin D1 that is
maximal at 3–5 h after this E2 administration (Tong and Pollard,
1999; Tong et al., 2008). Thus, prolonged E2 exposure (5 days) used
in this studymight have resulted in our experimentsmissing the transient
cyclin D1 nuclear inﬂux or, alternatively, longer E2 exposure (14 days)
as seen during the human menstrual cycle might be required for signiﬁ-
cant nuclear localization to be detected. Nevertheless, we have shown
that GSK3ß inhibition is sufﬁcient to induce human endometrial epi-
thelial proliferation and future studies will determine if it is necessary
for the E2-induced response in these cells.
A key rationale for this work is an attempt to verify whether the mol-
ecular mechanisms in response to E2 stimulation are identical or similar
between the human and mouse endometrium. Studies of human endo-
metrium have produced mixed results. Cell culture-models indicate
that, similar to the Muridae, growth of human endometrial epithelium
in response to E2 is mediated by the stromal cells via a presumably
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paracrine mechanism (Arnold et al., 2001; Pierro et al., 2001). Conver-
sely, a study of chimeric tissue recombinants that combined human and
mouse endometrial compartments concluded that the ER in the uterine
stroma is not necessary for the E2 response in human uterine epithelium
(Kurita et al., 2005). However, the chimeric model utilizes mouse
uterine stroma from the immature neonatal tissue. It is conceivable
that the mature adult mouse endometrium differs in hormonal and
growth response from its immature antecedent. Similarly, although
the disparate response in cyclin D1 localization in response to E2 may
represent a mechanistic difference between the mouse and human,
more work is needed to elucidate the central role of this machinery
of hormonal regulation in humans.
The studies showing that inhibition of GSK3ß induces DNA syn-
thesis in human endometrial cells may be especially important in
light of the fact that lithium is a commonly taken drug. Lithium has
been used for treatment of bipolar disorder since 1970s and has
been prescribed to millions of women worldwide. Endometrial hyper-
plasia has been reported in women with affective disorders who had
been treated with mood stabilizers (Joffe, 2007); yet, most of the
attention regarding menstrual disturbances in women with affective
disorders has focused on valproate, another frequently administered
drug. Valproate had been postulated to cause hyperandrogenism in
susceptible individuals and thereby trigger irregular menses (McIntyre
et al., 2003). However, the increased prevalence of menstrual disturb-
ances in women with bipolar disorder (up to 35–50%) has been
reported in at least one longitudinal study without an association
with valproate therapy, suggesting that menstrual disturbances may
be a common side effect for both lithium and valproate (Rasgon
et al., 2005). Valproate also possesses GSK3ß inhibitor properties
(Chen et al., 1999) and has a wide range of indications, including epi-
lepsy. More attention is needed to elucidate a possible link between
the increased menstrual disturbances in women taking lithium and
valproate, their possible common mediation via inhibition of GSK3ß,
and the consequent potential for the development of endometrial
proliferative disorders such as hyperplasia and carcinoma.
In summary, we have demonstrated that xenotransplantation of
human endometrial tissue can provide an excellent model in which
to study comparative endometrial biology. Treatment with lithium
induces a proliferative response of the human xenograft that mimics
the initial molecular control of endometrial proliferation in mice.
This model thus offers signiﬁcant promise. As recently illustrated by
others, one of the potential applications of the xenograft model lies
in the use of an identiﬁable marker, such as luciferase, that could be
introduced via genetic manipulation and allows for non-invasive
in-vivo assessment of the xenografted tissue (Masuda et al., 2007).
Further, this paradigm allows for the assessment of potentially toxic
agents that affect endometrial cell proliferation but cannot be given
to human volunteers.
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